Market Overview

Benzinga's Top Initiations

Related CRM
St. Jude Beats Earnings by a Penny - Analyst Blog
Updated Research Report on Salesforce - Analyst Blog
Salesforce.com Appoints Gen. Colin Powell to Board (Fox Business)
Related LXRX
Biotech Stock Roundup: MannKind PDUFA Date Pushed Out, Alkermes Impresses with Data - Analyst Blog
Encouraging Results from Lexicon Candidate - Analyst Blog

Analysts at Pivotal Research initiated coverage on shares of Salesforce.com (NYSE: CRM) with a “buy” rating. The target price for Salesforce.com is set to $66. Salesforce.com's shares closed at $53.05 yesterday.

Bank of America initiated coverage on shares of Lexicon Pharmaceuticals (NASDAQ: LXRX) with an “underperform” rating. The target price for Lexicon Pharmaceuticals is set to $1.50. Lexicon's shares closed at $1.9450 yesterday.

Analysts at JMP Securities initiated coverage on shares of SpringLeaf Holdings (NYSE: LEAF) with a “market outperform” rating. The target price for SpringLeaf Holdings is set to $26. SpringLeaf's shares closed at $21.83 yesterday.

HSBC initiated coverage on shares of Chevron (NYSE: CVX) with an “overweight” rating. The target price for Chevron is set to $138. Chevron's shares closed at $121.10 yesterday.

Posted-In: Top InitiationsDowngrades Analyst Ratings

 

Most Popular

Related Articles (CRM + CVX)

Around the Web, We're Loving...

Partner Network

Get Benzinga's News Delivered Free